Diagnostic performance of a multiplex PCR assay for meningitis in an HIV-infected population in Uganda

Diagnostic Microbiology and Infectious Disease

Volumn 84, Issue 3, 2016, Pages 268-273

  Rhein, Joshua ^a,b   Bahr, Nathan C ^a   Hemmert, Andrew C ^c   Cloud, Joann L ^c   Bellamkonda, Satya ^c   Oswald, Cody ^c   Lo, Eric ^c   Nabeta, Henry ^b   Kiggundu, Reuben ^b   Akampurira, Andrew ^b   Musubire, Abdu ^a,b   Williams, Darlisha A ^a,b   Meya, David B ^a,b   Boulware, David R ^a   Ndyetukira, Jane Francis ^d   Ahimbisibwe, Cynthia ^d   Kugonza, Florence ^d   Velamakanni, Sruti S ^d   Namudde, Alice ^d   Sadiq, Alisat ^d   Kandole, Tadeo Kiiza ^d   Kaboggoza, Julian ^d   Laker, Eva ^d   Luggya, Tony ^d   Tugume, Liliane ^d   Butler, Elissa ^d   Dyal, Jonathan ^d   Neborak, Julie ^d   King, Lexie ^d   Yueh, Nathan ^d   Hullsiek, Kathy Huppler ^d   Halupnick, Ryan ^d   Bohjanen, Paul R ^d   Kambugu, Andrew ^d   more..

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MAKERERE UNIVERSITY   (Uganda)

^c Idaho Technology Inc   (United States)

^d NONE

Author keywords

Cryptococcal meningitis; Diagnostics; HIV; Immunocompromised; Meningitis; PCR

Indexed keywords

AMPHOTERICIN;

ADULT; ARTICLE; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; COHORT ANALYSIS; COLONY FORMING UNIT; CONTROLLED STUDY; CRYOPRESERVATION; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EPSTEIN BARR VIRUS INFECTION; FEMALE; FILOBASIDIELLA; FUNGUS CULTURE; HUMAN; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOCOMPROMIZED PATIENT; INTERMETHOD COMPARISON; INTRACRANIAL PRESSURE; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MICROORGANISM DETECTION; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RELAPSE; REVERSE TRANSCRIPTION; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS PNEUMONIAE; UGANDA; VARICELLA ZOSTER VIRUS; AIDS RELATED COMPLEX; CD4 LYMPHOCYTE COUNT; IMMUNOCOMPROMISED PATIENT; MENINGITIS, CRYPTOCOCCAL; MICROBIOLOGY; PROCEDURES; REPRODUCIBILITY; STANDARDS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MENINGITIS; MENINGITIS, CRYPTOCOCCAL; MULTIPLEX POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; UGANDA;

EID: 84958664133     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2015.11.017     Document Type: Article

References (24)

1. Amuron B., Levin J., Birunghi J., Namara G., Coutinho A., Grosskurth H., et al. Mortality in an antiretroviral therapy programme in Jinja, south-east Uganda: a prospective cohort study. AIDS Res Ther 2011, 8:39.
2. Babady N.E. The FilmArray(r) respiratory panel: an automated, broadly multiplexed molecular test for the rapid and accurate detection of respiratory pathogens. Expert Rev Mol Diagn 2013, 13:779-788.
3. Bahr N., Boulware D.R., Marais S., Scriven J., Wilkinson R.J., Meintjes G. Central nervous system immune reconstitution inflammatory syndrome. Curr Infect Dis Rep 2013, 15:583-593.
4. Bahr N.C., Rolfes M.A., Musubire A., Nabeta H., Williams D.A., Rhein J., et al. Standardized electrolyte supplementation and fluid management improves survival during amphotericin therapy for cryptococcal meningitis in resource-limited settings. Open Forum Infect Dis 2014, 1:ofu070.
5. Bhagwan S., Naidoo K. Aetiology, clinical presentation, and outcome of meningitis in patients coinfected with human immunodeficiency virus and tuberculosis. AIDS Res Treat 2011, 2011:180352.
6. Bicanic T., Meintjes G., Wood R., Hayes M., Rebe K., Bekker L.G., et al. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. Clin Infect Dis 2007, 45:76-80.
7. Boulware D.R., Meya D.B., Bergemann T.L., Wiesner D.L., Rhein J., Musubire A., et al. Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. PLoS Med 2010, 7:e1000384.
8. Cohen D.B., Zijlstra E.E., Mukaka M., Reiss M., Kamphambale S., Scholing M., et al. Diagnosis of cryptococcal and tuberculous meningitis in a resource-limited African setting. Trop Med Int Health 2010, 15:910-917.
9. Durski K.N., Kuntz K.M., Yasukawa K., Virnig B.A., Meya D.B., Boulware D.R. Cost-effective diagnostic checklists for meningitis in resource-limited settings. J Acquir Immune Defic Syndr 2013, 63:e101-e108.
10. Evangelopoulos M.E., Koutoulidis V., Kilidireas K., Evangelopoulos D.S., Nakas G., Andreadou E., et al. Immune reconstitution inflammatory syndrome mimicking progressive multifocal leucoencephalopathy in a multiple sclerosis patient treated with natalizumab: a case report and review of the literature. J Clin Med Res 2015, 7:65-68.
11. Hakim J.G., Gangaidzo I.T., Heyderman R.S., Mielke J., Mushangi E., Taziwa A., et al. Impact of HIV infection on meningitis in harare, zimbabwe: a prospective study of 406 predominantly adult patients. AIDS 2000, 14:1401-1407.
12. Jarvis J.N., Meintjes G., Williams A., Brown Y., Crede T., Harrison T.S. Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases. BMC Infect Dis 2010, 10:67.
13. Katchanov J., Von Kleist M., Arasteh K., Stocker H. Time-to-amphotericin B' in cryptococcal meningitis in a European low-prevalence setting: analysis of diagnostic delays. QJM 2014, 107:799-803.
14. Liao C.H., Chi C.Y., Wang Y.J., Tseng S.W., Chou C.H., Ho C.M., et al. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with cryptococcal meningitis. J Microbiol Immunol Infect 2012, 45:296-304.
15. Meintjes G., Wilkinson R.J., Morroni C., Pepper D.J., Rebe K., Rangaka M.X., et al. Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 2010, 24:2381-2390.
16. Musubire A.K., Boulware D.R., Meya D.B., Rhein J. Diagnosis and management of cryptococcal relapse. J AIDS Clin Res 2013, Suppl 3(3):S3-003. pii: S3-003.
17. Park B.J., Wannemuehler K.A., Marston B.J., Govender N., Pappas P.G., Chiller T.M. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009, 23:525-530.
18. Pyrgos V., Seitz A.E., Steiner C.A., Prevots D.R., Williamson P.R. Epidemiology of cryptococcal meningitis in the US: 1997-2009. PLoS One 2013, 8:e56269.
19. Rajasingham R., Rhein J., Klammer K., Musubire A., Nabeta H., Akampurira A., et al. Epidemiology of meningitis in an HIV-infected Ugandan cohort. Am J Trop Med Hyg 2015, 92:274-279.
20. Rhein J., Boulware D.R. Prognosis and management of cryptococcal meningitis in patients with human immunodeficiency virus infection. Neurobehav HIV Med 2012, 4:45.
21. Ruggiero P., Mcmillen T., Tang Y.W., Babady N.E. Evaluation of the BioFire FilmArray respiratory panel and the GenMark eSensor respiratory viral panel on lower respiratory tract specimens. J Clin Microbiol 2014, 52:288-290.
22. Siddiqi O.K., Ghebremichael M., Dang X., Atadzhanov M., Kaonga P., Khoury M.N., et al. Molecular diagnosis of central nervous system opportunistic infections in HIV-infected Zambian adults. Clin Infect Dis 2014, 58:1771-1777.
23. Ward C., Stocker K., Begum J., Wade P., Ebrahimsa U., Goldenberg S.D. Performance evaluation of the Verigene® (Nanosphere) and FilmArray (BioFire®) molecular assays for identification of causative organisms in bacterial bloodstream infections. Eur J Clin Microbiol Infect Dis 2015, 34:487-496.
24. World Health Organization (WHO) Health topics: meningitis cited Jan 20, 2013, Available from:. http://www.who.int/topics/meningitis/en/.